#1 Clinical Trials Search in Europe

Diazepam

Diazepam, a widely used benzodiazepine medication, is being studied in various clinical trials to explore its potential in treating different medical conditions and to develop new formulations. These trials aim to evaluate the efficacy, safety, and bioavailability of diazepam in different forms and for various purposes, ranging from epilepsy management to alcohol withdrawal treatment.

Table of Contents

What is Diazepam?

Diazepam, also known by its brand name Valium[1], is a medication that belongs to a class of drugs called benzodiazepines. It’s widely prescribed for various medical conditions due to its calming effects on the brain and body. Diazepam works by enhancing the effects of a natural chemical in the body called gamma-aminobutyric acid (GABA), which helps to reduce anxiety, relax muscles, and prevent seizures[2].

Uses of Diazepam

Diazepam is used to treat several conditions, including:

  • Anxiety disorders: It can help reduce feelings of anxiety and panic[3].
  • Alcohol withdrawal: Diazepam can help manage symptoms of alcohol withdrawal syndrome, such as anxiety and agitation[7].
  • Seizures: It’s used to control certain types of seizures in people with epilepsy[5].
  • Muscle spasms: Diazepam can help relax muscles and reduce pain associated with muscle spasms[1].

  • Vertigo: Some research is exploring its use in treating acute peripheral vertigo, a condition that causes a spinning sensation[9].
  • Posttraumatic Stress Disorder (PTSD): There’s ongoing research into whether early administration of diazepam after a traumatic event could help prevent PTSD[3].

How Diazepam Works

Diazepam works by enhancing the effects of GABA, a neurotransmitter that reduces brain activity. This action helps to:

  • Calm the nervous system
  • Relax muscles
  • Reduce anxiety
  • Prevent seizures

By increasing GABA activity, diazepam can help restore balance in an overactive nervous system, leading to its various therapeutic effects[5].

Administration Methods

Diazepam can be administered in several ways, depending on the condition being treated and the patient’s needs:

  • Oral tablets: The most common form, taken by mouth[7].
  • Rectal gel: Used for emergency treatment of seizures, especially in children[6].
  • Nasal spray: A newer form being researched for rapid treatment of seizures[6][8].
  • Intravenous (IV) injection: Used in hospital settings for quick effect[9].
  • Vaginal administration: Being studied for treating pelvic pain and muscle spasms[1].

Side Effects

While diazepam can be effective for many conditions, it can also cause side effects. Common side effects may include:

  • Drowsiness or sleepiness
  • Dizziness
  • Weakness
  • Confusion
  • Changes in taste (with nasal spray formulations)[6]

More serious side effects can include respiratory depression (slowed breathing) and the potential for dependence with long-term use. It’s important to take diazepam only as prescribed by your doctor[7].

Ongoing Research

Researchers are continually studying diazepam to find new uses and improve its administration. Some areas of ongoing research include:

  • Using diazepam nasal spray for quick treatment of seizures[8].
  • Investigating its effects on blood pressure regulation[4].
  • Studying its potential in preventing PTSD when given shortly after a traumatic event[3].
  • Exploring its use in treating a specific type of epilepsy associated with GAD65 antibodies[5].
  • Evaluating its effectiveness in treating acute peripheral vertigo[9].

These studies aim to expand our understanding of diazepam and potentially find new ways to help patients with various conditions.

Aspect Details
Formulations Studied Intranasal sprays, nasal suspensions, intravenous, oral, rectal gel
Conditions Investigated Epilepsy, alcohol withdrawal, PTSD, peripheral vertigo, blood pressure regulation
Key Outcomes Measured Bioavailability, pharmacokinetics, seizure frequency, alcohol relapse rates, anxiety levels, blood pressure variability
Safety Assessments Nasal irritation, taste changes, adverse events, cardiovascular effects
Novel Applications Extended use in alcohol detoxification, early intervention for PTSD prevention, remote alcohol withdrawal management
Comparison Studies Intranasal vs. rectal gel, different dosages, placebo-controlled trials

FAQ

  • What conditions are being studied in diazepam clinical trials? Clinical trials are exploring diazepam's use in various conditions, including epilepsy, alcohol withdrawal, posttraumatic stress disorder (PTSD), peripheral vertigo, and blood pressure regulation in healthy individuals.
  • Are there new formulations of diazepam being tested? Yes, several trials are investigating new formulations of diazepam, such as intranasal sprays and nasal suspensions, comparing them to traditional forms like rectal gel and intravenous administration.
  • How is diazepam being studied for epilepsy treatment? Diazepam is being studied in various forms for epilepsy, including nasal sprays for acute seizure management and as a potential treatment for GAD65 antibody-associated epilepsy.
  • What is being investigated about diazepam in alcohol withdrawal treatment? One study is exploring the impact of extending diazepam treatment to one month during alcohol detoxification, hypothesizing that it may reduce early relapse rates in alcohol drinking.
  • Are there any studies looking at diazepam's effects on the cardiovascular system? Yes, there is a study investigating the acute effects of diazepam on beat-to-beat blood pressure variability and baroreflex control in healthy individuals.

Ongoing Clinical Trials on Diazepam

  • Study of anti-seizure drug combination in comatose patients with status epilepticus after cardiac arrest

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands

  • Study on the Effects of Sirolimus and Drug Combination for Children Under 4 Months with Tuberous Sclerosis Complex

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Germany

  • Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany Italy Spain

  • Study of diazepam and oxazepam in patients with benzodiazepine and opioid dependence who are receiving opioid agonist therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Norway

  • Study on Reducing Body Temperature in Healthy Volunteers Using Pethidine and Buspirone to Prevent Shivering

    Not recruiting

    1 1
    Investigated drugs:
    Norway

Glossary

  • Bioavailability: The extent and rate at which a drug enters the blood circulation and becomes available at the site of action in the body.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Intranasal: Administration of a drug through the nose, allowing it to be absorbed by the nasal mucosa.
  • GAD65 antibody: An antibody associated with certain types of epilepsy, targeting the enzyme glutamic acid decarboxylase (GAD65).
  • Baroreflex: A mechanism that helps regulate blood pressure by adjusting heart rate and blood vessel constriction in response to changes in blood pressure.
  • PTSD: Posttraumatic Stress Disorder, a mental health condition triggered by experiencing or witnessing a terrifying event.
  • Alcohol withdrawal syndrome: A set of symptoms that can occur when a person who has been drinking alcohol heavily for a prolonged period suddenly stops or significantly reduces their alcohol consumption.
  • Responsive Neurostimulator (RNS): An implanted device used to treat epilepsy by detecting abnormal brain activity and delivering electrical stimulation to prevent seizures.

References

  1. https://clinicaltrials.gov/study/NCT01696825
  2. https://clinicaltrials.gov/study/NCT01364558
  3. https://clinicaltrials.gov/study/NCT01221883
  4. https://clinicaltrials.gov/study/NCT05069779
  5. https://clinicaltrials.gov/study/NCT05361447
  6. https://clinicaltrials.gov/study/NCT02474407
  7. https://clinicaltrials.gov/study/NCT02242955
  8. https://clinicaltrials.gov/study/NCT05273398
  9. https://clinicaltrials.gov/study/NCT06293989